No Data
No Data
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
Moderna Options Spot-On: On April 17th, 83,342 Contracts Were Traded, With 858.25K Open Interest
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years
Most Shorted S&P 500 Stocks in March
Short Bets Against S&P 500 Healthcare Stock Rises in March; MRNA Stays Top Shorted
Pfizer, GSK to Benefit as CDC Panel Endorses Wider Availability of RSV Shots